Global Exporter & Bulk Supplier of Sunitcap 25 mg Capsule
π Introduction
Are you looking for a certified and reliable global partner for oncology medications? Ernest Oncology (a premier division of Ernest Pharmaceutical Pvt. Ltd.) is a leading international exporter and bulk supplier of Sunitcap 25 mg Capsules. We specialize in providing a high-quality, temperature-controlled supply chain for Sunitinib 25 mg to hospitals, clinics, and pharmaceutical wholesalers in the USA, UK, Australia, and South Africa.
π¬ Product Overview: Sunitcap 25 mg Capsule
Sunitcap 25 mg contains Sunitinib, a potent multi-targeted tyrosine kinase inhibitor (TKI). It is widely used in modern oncology for its effectiveness in blocking the signals that tell cancer cells to grow and divide.
Active Ingredient: Sunitinib (25 mg)
Therapeutic Class: Antineoplastic Agent / Tyrosine Kinase Inhibitor
Primary Indications: Advanced Renal Cell Carcinoma (RCC), Gastrointestinal Stromal Tumors (GIST), and Pancreatic Neuroendocrine Tumors (pNET).
π¦ Why Source from Ernest Oncology?
Global Reach: Dedicated export channels to the USA, UK, Australia, and South Africa.
Bulk Availability: Consistent stock levels for large-scale hospital requirements and tenders.
Quality Assurance: All products are sourced through validated pharmaceutical channels ensuring efficacy and safety.
Professional Logistics: Expert handling of international shipping documentation and cold-chain requirements where necessary.
PRESCRIPTION MEDICINE IS : YES
Disclaimer: Sunitcap 25 mg Capsule is a high-potency prescription medication. It must only be used under the direct supervision of a qualified oncologist. This post is for B2B informational purposes and pharmaceutical trade only; it does not replace professional medical advice. Always consult a healthcare provider before starting any treatment.